3'-(4-Phenyl-6-(2''-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1':2',1''-terphenyl]-2-yl)pyrimidin-2-yl)-[1,1'-biphenyl]-2-carbonitrile

Catalog No. :
ACAAGC156
CAS No. :
2920623-81-8
Molecular Formula :
C47H38BN3O2
Molecular Weight :
687.65

IUPAC Name:3'-(4-phenyl-6-(2''-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1':2',1''-terphenyl]-2-yl)pyrimidin-2-yl)-[1,1'-biphenyl]-2-carbonitrile

3'-(4-Phenyl-6-(2''-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1':2',1''-terphenyl]-2-yl)pyrimidin-2-yl)-[1,1'-biphenyl]-2-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3'-(4-Phenyl-6-(2''-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1':2',1''-terphenyl]-2-yl)pyrimidin-2-yl)-[1,1'-biphenyl]-2-carbonitrile
IUPAC Name3'-(4-phenyl-6-(2''-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1':2',1''-terphenyl]-2-yl)pyrimidin-2-yl)-[1,1'-biphenyl]-2-carbonitrile
Molecular FormulaC47H38BN3O2
Molecular Weight687.65
SMILESN#CC1=CC=CC=C1C2=CC=CC(C3=NC(C4=C(C5=C(C6=C(B7OC(C)(C(C)(C)O7)C)C=CC=C6)C=CC=C5)C=CC=C4)=CC(C8=CC=CC=C8)=N3)=C2
InChI KeyFKQXXADDVGYEKN-UHFFFAOYSA-N
CAS No.2920623-81-8

Synthetic Route by SureRoute

1. ACAAGC156 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAAGC156 route product structure diagram
    ACAAGC1562920623-81-8
Inquiry

2. ACAAGC156 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACATGM867 route compound structure diagram
    ACATGM867138642-62-3 In Stock
  4. Then
  5. ACAAGC156 route product structure diagram
    ACAAGC1562920623-81-8
Inquiry

Comments (0)